Research Article
[Retracted] The Study on the Pathogenesis of Pediatric Lymphoma Based on the Combination of Pseudotargeted and Targeted Metabolomics
Table 2
MRM transitions, collision energy, and precision of the method.
| | Compounds | (min) | Parent ion | Product ion | CE (eV) | Precision RSD% |
| | Taurine | 4.7 | 124.0 | 80.0 | -34 | 7.4% | | Leucine | 5.8 | 130.1 | 112.0 | 33 | 8.0% | | Creatine | 6.2 | 132.0 | 90.0 | 30 | 5.0% | | Urea | 0.66 | 61.1 | 44.2 | 40 | 4.7% | | (6Z,9Z,12Z)-Octadecatrienoic acid | 9.2 | 279.2 | 95.0 | -26 | 7.7% | | Linoleate | 1.4 | 281.0 | 81.0 | 39 | 12.6% | | Octadecenoic acid | 10.0 | 283.3 | 69.0 | 37 | 9.2% | | L-Palmitoylcarnitine | 8.0 | 400.3 | 85.0 | 42 | 4.6% | | Hexadecanoic acid | 9.7 | 257.2 | 57.0 | 34 | 12.0% | | Tetradecanoic acid | 1.5 | 229.1 | 211.2 | 17 | 4.5% | | (9Z)-Hexadecenoic acid | 1.4 | 255.1 | 237.1 | 20 | 5.0% | | Uric acid | 4.4 | 167.0 | 124.0 | -22 | 6.5% | | Glucose | 3.2 | 179.1 | 89.1 | -36 | 3.3% | | 1-Methylnicotinamide | 3.0 | 137.1 | 94.0 | 32 | 11.5% | | Hypoxanthine | 1.1 | 137.0 | 110.0 | 21 | 12.0% | | L-Glutamine | 6.7 | 145.1 | 127.0 | -19 | 9.5% | | Carnitine | 6.9 | 162.1 | 103.0 | 26 | 8.5% |
|
|
